검색어: pimarjament (몰타어 - 영어)

għandha tintuża kawtela meta parareg tingħata ma’ mediċini, ttitrati individwalment li għandhom indiċi terapewtiku dejjaq u li huma metabolizzati pimarjament minn cyp2d6.
caution should be exercised when parareg is administered with individually titrated, narrow therapeutic index medications that are predominantly metabolised by cyp2d6.

jista’ jkun hemm bżonn ta’ aġġustament fid-doża ta’ mediċini ttitrati individwalment, li għandhom indiċi terapewtiku dejjaq u li huma metabolizzati pimarjament minn cyp2d6 (e.ż., flecainide, propafenone, metoprolol mogħti f’każijiet ta’ insuffiċjenza tal-qalb, desipramine, nortriptyline, clomipramine) meta dawn jingħataw flimkien ma’ parareg (ara sezzjoni 4.4).
dose adjustments of concomitant medicinal products may be required when parareg is administered with individually titrated, narrow therapeutic index substances that are predominantly metabolised by cyp2d6 (e.g., flecainide, propafenone, metoprolol given in heart failure, desipramine, nortriptyline, clomipramine) (see section 4.4).